Shares of Bruker BRKR moved higher by 0.06% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share fell 36.36% year over year to $0.21, which beat the estimate of $0.06.
Revenue of $424,600,000 declined by 13.38% from the same period last year, which beat the estimate of $390,920,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Bruker hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Aug 03, 2020
Time: 04:30 PM
Recent Stock Performance
Company's 52-week high was at $54.49
Company's 52-week low was at $30.78
Price action over last quarter: Up 16.03%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.